{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:46:41Z","timestamp":1793317601449,"version":"4.5.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"NIH","award":["R01 AG081359"],"award-info":[{"award-number":["R01 AG081359"]}]},{"DOI":"10.13039\/100022914","name":"Claude D. Pepper Older Americans Independence Center, School of Medicine, University of Maryland","doi-asserted-by":"publisher","award":["P30 AG024827"],"award-info":[{"award-number":["P30 AG024827"]}],"id":[{"id":"10.13039\/100022914","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"DOI":"10.1007\/s00223-025-01364-y","type":"journal-article","created":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T09:40:57Z","timestamp":1743327657000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Impact of Zoledronic Acid on Bone Mineral Density and Trabecular Score Following Denosumab Discontinuation in Older Adults in Long-Term Care"],"prefix":"10.1007","volume":"116","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5115-5980","authenticated-orcid":false,"given":"Nami Safai","family":"Haeri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subashan","family":"Perera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan L.","family":"Greenspan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,27]]},"reference":[{"issue":"8","key":"1364_CR1","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1001\/jama.284.8.972","volume":"284","author":"JM Chandler","year":"2000","unstructured":"Chandler JM, Zimmerman SI, Girman CJ, Martin AR, Hawkes W, Hebel JR, Sloane PD, Holder L, Magaziner J (2000) Low bone mineral density and risk of fracture in white female nursing home residents. JAMA 284(8):972\u2013977","journal-title":"JAMA"},{"issue":"2","key":"1364_CR2","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00198-011-1582-5","volume":"23","author":"LA Beaupre","year":"2012","unstructured":"Beaupre LA, Majumdar SR, Dieleman S, Au A, Morrish DW (2012) Diagnosis and treatment of osteoporosis before and after admission to long-term care institutions. Osteoporos Int 23(2):573\u2013580","journal-title":"Osteoporos Int"},{"issue":"12","key":"1364_CR3","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1016\/j.jamda.2022.09.013","volume":"23","author":"JD Niznik","year":"2022","unstructured":"Niznik JD, Gilliam MA, Col\u00f3n-Emeric C, Thorpe CT, Lund JL, Berry SD, Hanson LC (2022) Controversies in osteoporosis treatment of nursing home residents. J Am Med Dir Assoc 23(12):1928\u20131934","journal-title":"J Am Med Dir Assoc"},{"issue":"8","key":"1364_CR4","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1056\/NEJMoa0809493","volume":"361","author":"SR Cummings","year":"2009","unstructured":"Cummings SR, San Martin J, McClung MR, Siris ES, Eastell R, Reid IR, Delmas P, Zoog HB, Austin M, Wang A, Kutilek S, Adami S, Zanchetta J, Libanati C, Siddhanti S, Christiansen C, FREEDOM Trial (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 361(8):756\u2013765","journal-title":"N Engl J Med"},{"issue":"2","key":"1364_CR5","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/jgs.19260","volume":"73","author":"SL Greenspan","year":"2024","unstructured":"Greenspan SL, Perera S, Haeri NS, Nace DA, Resnick NM (2024) Denosumab for osteoporosis in older adults in long-term care: a randomized trial. J Am Geriatr Soc 73(2):445\u2013457","journal-title":"J Am Geriatr Soc"},{"issue":"5","key":"1364_CR6","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1007\/s00198-017-3919-1","volume":"28","author":"MR McClung","year":"2017","unstructured":"McClung MR, Wagman RB, Miller PD, Wang A, Lewiecki EM (2017) Observations following discontinuation of long-term denosumab therapy. Osteoporos Int 28(5):1723\u20131732","journal-title":"Osteoporos Int"},{"issue":"2","key":"1364_CR7","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/jbmr.3337","volume":"33","author":"SR Cummings","year":"2018","unstructured":"Cummings SR, Ferrari S, Eastell R, Gilchrist N, Jensen JB, McClung M, Roux C, T\u00f6rring O, Valter I, Wang AT, Brown JP (2018) Vertebral fractures after discontinuation of denosumab: a post hoc analysis of the randomized placebo-controlled FREEDOM trial and its extension. J Bone Miner Res 33(2):190\u2013198","journal-title":"J Bone Miner Res"},{"key":"1364_CR8","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa756","author":"E Tsourdi","year":"2020","unstructured":"Tsourdi E, Zillikens MC, Meier C, Body JJ, Gonzalez Rodriguez E, Anastasilakis AD, Abrahamsen B, McCloskey E, Hofbauer LC, Gua\u00f1abens N, Obermayer-Pietsch B, Ralston SH, Eastell R, Pepe J, Palermo A, Langdahl B (2020) Fracture risk and management of discontinuation of denosumab therapy: a systematic review and position statement by ECTS. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/clinem\/dgaa756","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"1364_CR9","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.4065\/83.9.1032","volume":"83","author":"MT Drake","year":"2008","unstructured":"Drake MT, Clarke BL, Khosla S (2008) Bisphosphonates: mechanism of action and role in clinical practice. Mayo Clin Proc 83(9):1032\u20131045","journal-title":"Mayo Clin Proc"},{"issue":"10","key":"1364_CR10","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1007\/s00198-021-05900-y","volume":"33","author":"MS LeBoff","year":"2022","unstructured":"LeBoff MS, Greenspan SL, Insogna KL et al (2022) The clinician\u2019s guide to prevention and treatment of osteoporosis. Osteoporos Int 33(10):2049\u20132102","journal-title":"Osteoporos Int"},{"issue":"3","key":"1364_CR11","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1385\/JCD:2:3:275","volume":"2","author":"LF Varney","year":"1999","unstructured":"Varney LF, Parker RA, Vincelette A, Greenspan SL (1999) Classification of osteoporosis and osteopenia in postmenopausal women is dependent on site-specific analysis. J Clin Densitom 2(3):275\u2013283","journal-title":"J Clin Densitom"},{"issue":"3","key":"1364_CR12","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.jocd.2011.05.005","volume":"14","author":"D Hans","year":"2011","unstructured":"Hans D, Barthe N, Boutroy S, Pothuaud L, Winzenrieth R, Krieg MA (2011) Correlations between trabecular bone score, measured using anteroposterior dual-energy X-ray absorptiometry acquisition, and 3-dimensional parameters of bone microarchitecture: an experimental study on human cadaver vertebrae. J Clin Densitom 14(3):302\u2013312","journal-title":"J Clin Densitom"},{"issue":"11","key":"1364_CR13","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.1002\/jbmr.499","volume":"26","author":"D Hans","year":"2011","unstructured":"Hans D, Goertzen AL, Krieg M-A, Leslie WD (2011) Bone microarchitecture assessed by TBS predicts osteoporotic fractures independent of bone density: the Manitoba study. J Bone Miner Res 26(11):2762\u20132769","journal-title":"J Bone Miner Res"},{"issue":"3","key":"1364_CR14","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jocd.2017.06.019","volume":"20","author":"E Shevroja","year":"2017","unstructured":"Shevroja E, Lamy O, Kohlmeier L, Koromani F, Rivadeneira F, Hans D (2017) Use of trabecular bone score (TBS) as a complementary approach to dual-energy X-ray absorptiometry (DXA) for fracture risk assessment in clinical practice. J Clin Densitom 20(3):334\u2013345","journal-title":"J Clin Densitom"},{"issue":"3","key":"1364_CR15","doi-asserted-by":"publisher","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","volume":"56","author":"LP Fried","year":"2001","unstructured":"Fried LP, Tangen CM, Walston J et al (2001) Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56(3):M146\u2013M157","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"4","key":"1364_CR16","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1191\/0269215502cr515oa","volume":"16","author":"SK Rigler","year":"2002","unstructured":"Rigler SK, Studenski S, Wallace D, Reker DM, Duncan PW (2002) Co-morbidity adjustment for functional outcomes in community-dwelling older adults. Clin Rehabil 16(4):420\u2013428","journal-title":"Clin Rehabil"},{"issue":"12","key":"1364_CR17","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1002\/jbmr.3853","volume":"34","author":"AD Anastasilakis","year":"2019","unstructured":"Anastasilakis AD, Papapoulos SE, Polyzos SA, Appelman-Dijkstra NM, Makras P (2019) Zoledronate for the prevention of bone loss in women discontinuing denosumab treatment. a prospective 2-year clinical trial. J Bone Miner Res 34(12):2220\u20132228","journal-title":"J Bone Miner Res"},{"key":"1364_CR18","first-page":"S17","volume":"S1","author":"JN Tsai","year":"2019","unstructured":"Tsai JN, David N, Sassana G, Leder BZ (2019) Zoledronic acid maintains bone mineral density after denosumab administration (DATA-HD Extension). J Bone Miner Res S1:S17","journal-title":"J Bone Miner Res"},{"issue":"6","key":"1364_CR19","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1002\/jbmr.3110","volume":"32","author":"AD Anastasilakis","year":"2017","unstructured":"Anastasilakis AD, Polyzos SA, Makras P, Aubry-Rozier B, Kaouri S, Lamy O (2017) Clinical features of 24 patients with rebound-associated vertebral fractures after denosumab discontinuation: systematic review and additional cases. J Bone Miner Res 32(6):1291\u20131296","journal-title":"J Bone Miner Res"},{"issue":"10","key":"1364_CR20","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1002\/jbmr.4098","volume":"35","author":"AS S\u00f8lling","year":"2020","unstructured":"S\u00f8lling AS, Harsl\u00f8f T, Langdahl B (2020) Treatment with zoledronate subsequent to denosumab in osteoporosis: a randomized trial. J Bone Miner Res 35(10):1858\u20131870","journal-title":"J Bone Miner Res"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-025-01364-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00223-025-01364-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-025-01364-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T13:20:47Z","timestamp":1766755247000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00223-025-01364-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,27]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1364"],"URL":"https:\/\/doi.org\/10.1007\/s00223-025-01364-y","relation":{},"ISSN":["1432-0827"],"issn-type":[{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,27]]},"assertion":[{"value":"3 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Drs. Safai Haeri, Perera, and Greenspan report no conflicts of interest in the subject matter or materials discussed in this manuscript. Drs. Greenspan and Perera are investigators of other NIH-funded trials where study medication is provided by Amgen.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This\u00a0research was conducted\u00a0under protocol 1483CESC, which received approval from our local Ethics Committee. This research\u00a0adhered to the ethical standards set forth in the 1964 Helsinki Declaration and its subsequent amendments or equivalent guidelines. All participants provided written informed consent prior to their involvement in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"55"}}